cancer clinical trials for Myeloma/Plasma Cell Dyscrasia (ONC)

9 Myeloma/Plasma Cell Dyscrasia (ONC) clinical trials found. View a list of all cancer clinical trial types.

• A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (CCS1477-04)

  Current Status: Open

  View links and contact information related to this clinical trial

• Randomized Phase II Study of Iberdomide Maintenance Therapy Following Idecaptagene Vicleucel CAR-T in Multiple Myeloma Patients

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Protocol (EAP) For Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming For Commercial Release

  Current Status: Open

  View links and contact information related to this clinical trial

• Intermediate-Size Population Expanded Access Program (EAP) for cilta-cel Out-of-Specification (OOS) in Patients with Multiple Myeloma

  Current Status: Open

  View links and contact information related to this clinical trial

• Cognition in older adults with myeloma undergoing CAR-T therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab SC and Lenalidomide (Tal-DR) Versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant as Initial Therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I Multicenter, Open-Label Study to Determine the Recommended Dose and Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants with Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose For Each Add On Investigational Component

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients with Newly Diagnosed AL Amyloidosis

  Current Status: Open

  View links and contact information related to this clinical trial

• An Observational Study Associating Adiponectin Signaling with Acute and Chronic Toxicity Following Pelvic Radiation

  Current Status: Open

  View links and contact information related to this clinical trial